Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma

Fig. 2

Tumor-derived mutations in plasma samples of PwHCC displayed heterogeneity. A Proportion of different mutation groups in tumor tissues from 55 PwHCC, including mutations overlapping WBC-mutations (FFPE-share-WBC), with mutations detected in paired plasma samples (TDMs or FFPE-share-LB unique) or those uniquely detected in tumor tissues (FFPE-unique). B Oncoprint plots of distributions of TDMs in 49 PwHCC with paired plasma and tumor tissues. Rows and columns represent TDMs and patients, respectively. Mutations are labeled on the right side. The left-side bar plot shows the occurrences of each mutation, among all patients, while the top most bar plot represents the mutational loads of each patient. HCC Patients are grouped according to their tumor stages

Back to article page